Shopping Cart
- Remove All
- Your shopping cart is currently empty
PCAF-IN-1 is a highly selective PCAF (p300/CBP-associated factor) inhibitor with potential anti-tumor, anti-inflammatory, and anti-heart disease effects. Inhibition of PCAF attenuates cardiac remodeling after myocardial infarction, reduces polarization of M1-type macrophages, and attenuates autoimmune arthritis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $75 | In Stock | |
5 mg | $129 | In Stock | |
10 mg | $216 | In Stock | |
25 mg | $439 | In Stock | |
50 mg | $646 | In Stock | |
100 mg | $918 | In Stock | |
200 mg | $1,250 | In Stock |
Description | PCAF-IN-1 is a highly selective PCAF (p300/CBP-associated factor) inhibitor with potential anti-tumor, anti-inflammatory, and anti-heart disease effects. Inhibition of PCAF attenuates cardiac remodeling after myocardial infarction, reduces polarization of M1-type macrophages, and attenuates autoimmune arthritis. |
In vitro | Methods: Hepatocellular carcinoma (HePG-2), breast cancer (MCF-7), prostate cancer (PC3), and colorectal cancer (HCT-116) cells were treated with PCAF-IN-1 (10 μM, 72 hours), and cell viability was measured by MTT. Results: PCAF-IN-1 showed the strongest antitumor activity against human cancer cell lines. [1]. |
Molecular Weight | 310.74 |
Formula | C15H11ClN6 |
Cas No. | 2439194-86-0 |
Smiles | ClC=1C=CC(=CC1)C2=NN=C3C=4C=CC=CC4C(=NN)NN23 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 0.1 mg/mL (0.32 mM), Sonication and heating are recommended. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.